• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money
Moneycontrol

Home » News » Business

Feb 17, 2017, 02.12 PM | Source: PTI

DRL says no claims for monetary damages in US patent case

Drug major Dr Reddy's Laboratories had received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.

Like this story, share it with millions of investors on M3

DRL says no claims for monetary damages in US patent case

Drug major Dr Reddy's Laboratories had received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.

Post Your Comments

Share Cancel

| 1 Comments
DRL says no claims for monetary damages in US patent case
Drug major Dr Reddy's Laboratories on Friday  said there are no claims against the company for monetary damages after it received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.

"We would like to state that there are no claims against the company for monetary damages because the proposed palonosetron product has not been marketed," Dr Reddy's Laboratories said in a BSE filing.

"As for 'quantum of claims', the claims only sought injunctive relief against the company to prohibit the manufacturing, use, import and sale of the company's palonosetron product prior to expiration of the patents-in-suit.

"Therefore, the company believes there is no monetary 'compensation' or 'penalty' damages owed to Helsinn due to this decision," it added.

Dr Reddy's Laboratories yesterday said it has received an unfavourable ruling in a US court regarding a patent infringement case over Aloxi.

"The United States District Court for the District of New Jersey issued its opinion regarding Helsinn Healthcare's patent infringement claims against Dr Reddy's proposed palonosetron product," the company said.

"The court found that Dr Reddy's proposed palonosetron hydrochloride 0.25 mg/5 ml infringes on certain claims of US patents...and that the asserted claims were not valid," it added.

Helsinn Healthcare SA is a Switzerland-based pharma company.

"We are disappointed in the decision and intend to pursue an appeal in due course," a company spokesperson said.

Aloxi injection is used in adults to help prevent nausea and vomiting due to chemotherapy.

Shares of Dr Reddy's were trading at Rs 2,922.10 apiece, down 0.16 per cent on BSE.

Buy, Hold, Sell ? Hear it first on M3
DRL says no claims for monetary damages in US patent case

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login